[Rational imaging of metastasized tumor diseases].

H J Stemmler1, M Schlemmer, S Reilich

  • 1Medizinische Klinik und Poliklinik III, Hämatologie und Onkologie, Ludwig-Maximilians-Universität München, Campus Großhadern, Marchioninistr. 15, 81377 München, Deutschland. joachim.stemmler@med.uni-muenchen.de

Der Internist
|June 6, 2013
PubMed
Summary

Predicting patient response to anticancer drugs remains challenging. This review highlights the crucial role of imaging techniques, like computed tomography (CT), in monitoring tumor shrinkage and assessing anticancer therapy effectiveness in metastatic cancer patients.